90
Participants
Start Date
May 1, 2025
Primary Completion Date
December 1, 2026
Study Completion Date
December 1, 2026
5U/0,1 ml Botulinum toxin A
Botox® 100 U (AbbVie) will be dissolved in 2 milliliters of room-temperature sterile isotonic saline, resulting in a solution concentration of 5 U/0.1 mL. Each patient will receive a total dose of 50 U, administered bilaterally into the masseter and temporalis muscles.
10U/0,1 ml Botulinum toxin A
Botox® 100 U (AbbVie) will be dissolved in 1 milliliters of room-temperature sterile isotonic saline, resulting in a solution concentration of 10 U/0.1 mL. Each patient will receive a total dose of 100 U, administered bilaterally into the masseter and temporalis muscles.
RECRUITING
Eastman institute Folktandvården Region Stockholm, Stockholm
Region Stockholm
OTHER_GOV